TA

Taro Pharmaceutical Industries LtdNYSE TARO Stock Report

Last reporting period 31 Mar, 2024

Updated —

Last price

Market cap $B

1.615

Small

Exchange

XNYS - New York Stock Exchange, Inc

View Section: Eyestock Rating

Taro Pharmaceutical Fair Value

TA

TARO stock is not valued by Eyestock.

Historical price or reporting data is not enough to analyze the value of the company

Discover Undervalued Companies


Taro Pharmaceutical Valuation

The fair value level of 41.16 USD can be considered as an effective entry point for long-term investors to start investing in TARO stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.

Price chart is not available

1y
3y
5y
All time
Market price

Current market price

Fair value

Min value

Max value

19.09.2024

Market price:

* Eyestock is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on eyestock.io represent a recommendation to buy or sell a security.

Taro Pharmaceutical Industries Ltd price metrics

-13.1

Annual return (geometric mean)

33.9

Risk (standard deviation) of returns

β

-0.1

Beta (volatility compared to market)

It means that TARO stock and the market have an inverse correlation
View Section: Financials